In previous experiments a correlation was found between the amount of IgE on human basophils and the IgE serum level. The results of these experiments are shown to fit a free exchange model with an approximately constant K-value. We investigated whether the free IgE-receptors on the basophils, which should be present according to this model, could be saturated by incubating the cell suspensions with IgE myeloma protein or with sera from patients with an elevated IgE serum level. Various incubation conditions were applied in sensitizing the leukocytes, and cells from both atopic and nonatopic subjects were used for testing, but no increase in basophil-bound IgE could be measured with the quantitative immunofluorescence technique. Nor could we demonstrate a significant dissociation of cell-bound IgE in a period of 24 h. Therefore another hypothesis is put forward, in which receptor turnover is taken into account: we assumed that the free receptors on the basophils had a shorter functional half-life, than the half-life of the IgE-receptor complexes. This model would explain the contradictory results mentioned above.

This content is only available via PDF.
© 1977 S. Karger AG, Basel
1977
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.